Company intelligence / Profile preview
Kashiv BioSciences
Piscataway, New Jersey, United Stateskashivbiosciences.com ↗
- Ownership
- Private
- Employees
- ~300
- Development stage
- Commercial
01
Overview
Kashiv BioSciences has achieved Health Canada approval for its Pegfilgrastim Injection (“Pexegra”), a G-CSF biosimilar now commercially available in Canada. Its omalizumab biosimilar candidate ADL‑018 has been accepted for review by the UK MHRA. The abatacept biosimilar KSHB002 reported successful Phase 1 results in early 2025. The company maintains a robust pipeline of advanced clinical and commercial-stage assets focused on expanding access to high-quality biologic medicines globally
- Therapeutic areas
- OncologyImmunology
- Modalities
- Monoclonal antibodies (mAbs)complex proteins/biologicsbiosimilarspeptide-based medicines
- Industry
- Biotech
02
Drug pipeline
13 assets12 more assets in the full pipeline.
03
Partnerships
JAMP Pharma Group—Canadian commercialization partner for Pegfilgrastim Injection (“Pexegra”)GoldenTree Asset Management—$150M debt financing partner supporting expansion efforts
Beyond the preview
Go deeper on Kashiv BioSciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kashiv BioSciences.